Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 studyMarina Elena Cazzaniga, Massimiliano Mazza, G. Pinotti et al.|The Breast|2019Cited by 58
MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expressionSilvia Uccella, C. Capella, Maria Grazia Tibiletti et al.|Journal of Clinical Pathology|2009Cited by 20
P1.01-053 Italian Nivolumab Expanded Access Programme (EAP): Data from Patients with Advanced Non-Squamous NSCLC and Brain MetastasesLucio Crinò, Angelo Delmonte, Paolo Bidoli et al.|Journal of Thoracic Oncology|2017Cited by 8
Efficacy and safety data from patients with advanced non-squamous NSCLC and brain metastases from the nivolumab expanded access programme (EAP) in ItalyLucio Crinò, Angelo Delmonte, Paolo Bidoli et al.|Annals of Oncology|2017Cited by 7